Epidemiologic Research Studies of Acquired Immunodeficiency Syndrome (AIDS) and Human Immunodeficiency Virus (HIV) Infection in Selected Population Groups
Active
- Assistance listing
- 93.943
- Agency
-
Centers for Disease Control and Prevention
Department of Health and Human Services
- Grant awards
- 143 $313,216,345 in federal obligations
Program facts
- Also known as
- Minority HIV Research Initiative (MARI) to Support Epidemiologic and Implementation
- Assistance types
-
- Cooperative Agreement
- Block Grant
- Project Grant
- Treasury account
-
- 75-0950-0-1-550
- More information
Program details come from SAM.gov Assistance Listings. Updated . Grant award figures come from USAspending.gov.
About this program
The Centers for Disease Control and Prevention (CDC) under the Department of Health and Human Services is funding epidemiologic and implementation science research on HIV and AIDS in racial and ethnic minority communities disproportionately affected by HIV, Assistance Listing 93.943, with the most recent grant award dated September 1, 2014.
The program is inactive from a new-award perspective. The portfolio shows 143 awards spanning from 2002 to 2014, with highly variable annual activity: the program issued 36 awards in 2010, but only 3 in 2014, and no new awards have been disbursed in the past 12 years. Opportunities remain open; CDC posted RFA-PS-24-063 (Minority HIV Research Initiative) on October 11, 2023, with a due date of January 16, 2024, soliciting epidemiologic, behavioral, and implementation science research addressing health inequities in racial and ethnic minority communities with HIV and building research capacity among historically underrepresented investigators.
Funded activities center on HIV care engagement, retention, and viral suppression. Representative recent awards include the Cooperative Re-Engagement Controlled Trial (CoRECT) projects: Connecticut's Project Connect ($2.27 million) establishing data-monitoring systems to improve linkage and retention in HIV medical care by integrating surveillance, clinical, and pharmacy databases across 23 treatment sites; Philadelphia's CoRECT ($2.18 million) demonstrating health-department-led outreach to re-engage persons out of care through randomized comparison; and Massachusetts's MassReach ($2.08 million) evaluating health-department-clinic collaboration to identify out-of-care individuals and achieve viral suppression. The 2010 cohort funded Expanded HIV Testing for Disproportionately Affected Populations across multiple jurisdictions at awards ranging from approximately $972 thousand to $8.7 million.
The portfolio is predominantly Cooperative Agreements (121 awards, 85 percent) with smaller shares of Project Grants (12 awards, 8 percent) and Block Grants (10 awards, 7 percent). Funding is concentrated entirely within CDC, which obligated $311.1 million across 142 awards. Combined federal dollars obligated across the full portfolio total $313.2 million. Typical awards fall in the $1.5 million to $3 million range for multi-year cooperative agreements with periods of performance up to five years. Eligible applicants include state and local health agencies, nonprofit and for-profit research organizations, American Indian/Alaska Native tribal governments and organizations, and persons physically afflicted with AIDS or HIV infection.
Objective and description
- Objective
To support promising epidemiologic and implementation of science research in racial/ethnic minority communities disproportionately affected by HIV, while strengthening the capacity for conducting such research among investigators working in these com
- Description
The EHE plan encompasses the following four key strategies: (i) diagnose all individuals with HIV as early as possible; (ii) treat people with HIV rapidly and effectively to reach sustained viral suppression; (iii) prevent new HIV transmissions by using proven interventions, including PrEP and syringe services programs (SSPs); (iv) respond quickly to potential HIV outbreaks to get needed prevention and treatment services to people who need them.
Eligibility
- Applicant eligibility
Reference posted NOFOs available on Grants.gov
- Beneficiary eligibility
State and local health agencies; private research organizations, public and private nonprofit organizations, for profit organizations; minority groups, including American Indian/Alaska Native tribal governments or tribal organizations located wholly or in part within their boundaries, and persons physically afflicted with AIDS/HIV infection.
- Uses of assistance
Assistance is provided to support cooperative agreements that examine important epidemiologic research issues concerning AIDS and HIV infection. The research should contribute to the health services knowledge base from which empirically based information can be derived by policy makers, both immediately and over the coming decades. Grants include funds for direct costs (such as personnel, travel, equipment, or supplies) necessary to carry out an approved project as well as funds for the reimbursement of applicable indirect costs. Unallowable costs, as well as those for which prior written approval is required, are indicated in the HHS Grants Policy Statement.
- Length and time phasing of assistance
Financial assistance is provided for a 12-month budget period with a period of performance of up to five years subject to the availability of funds and satisfactory progress of the recipient.
How to apply
- Criteria for selecting proposals
Applications will be evaluated on the review criteria described in the Notice of Funding Opportunity Announcements (NOFOs). In general, the review and selection process of complete and responsive applications to the NOFO consists of determination of the scientific and technical merit by objective or peer review, availability of funds, and relevance of program priorities and the priorities of CDC.
- Award procedure
After review and approval, a Notice of Award (NoA) will be prepared and processed, along with appropriate notification to the public.
- Deadlines
Check Grants.gov for any relevant NOFO information regarding processes for applying for assistance.
- Renewals
Cooperative agreement period of performance is 1 to 5 years. After initial awards, and subject to availability of funds, projects may be continued non-competitively contingent upon satisfactory progress by the recipient (as documented in required reports) and the determination that continued funding is in the best interest of the Federal government.
Grant opportunities
Grant awards
Latest 10 of 143 listed here. See the rest on GovTribe.
Top recipients by federal obligations
| Rank | Recipient | Federal obligations | Share |
|---|---|---|---|
| 1 | Johns Hopkins University | $40,685,040 | 13% |
| 2 | City Of New York | $10,432,599 | 3% |
| 3 | National Blood Transfusion SE Rvices | $8,150,000 | 3% |
| 4 | Florida Department Of Health | $7,730,255 | 2% |
| 5 | Health Research, Inc. | $6,424,384 | 2% |
| 6 | California Department Of Public Health | $6,243,369 | 2% |
| 7 | North Carolina Department Of Health & Human Services | $6,127,833 | 2% |
7 of 112 recipients listed here. See the rest on GovTribe.
Federal obligations by fiscal year
| Fiscal year | Federal obligations |
|---|---|
| FY2024 | $2,993,298 |
| FY2023 | $4,009,144 |
| FY2022 | $5,083,494 |
| FY2021 | $1,344,550 |
| FY2019 | -$115,134 |
| FY2018 | $600,000 |
| FY2017 | $1,936,620 |
| FY2016 | $2,608,933 |
| FY2015 | $1,708,636 |
| FY2014 | $612,026 |
| FY2013 | $1,283,849 |
| FY2012 | $16,106,709 |
| FY2011 | $36,284,697 |
| FY2010 | $93,595,205 |
| FY2009 | $69,848,261 |
| FY2008 | $77,515,743 |
| FY2007 | $79,746,549 |
| FY2005 | $727,942 |
| FY2004 | $655,871 |
Show all 19
Quick answers
What is Assistance Listing 93.943?
Assistance Listing 93.943 is Epidemiologic Research Studies of Acquired Immunodeficiency Syndrome (AIDS) and Human Immunodeficiency Virus (HIV) Infection in Selected Population Groups, a federal grant program run by Centers for Disease Control and Prevention (Department of Health and Human Services).
What is the CFDA number for Epidemiologic Research Studies of Acquired Immunodeficiency Syndrome (AIDS) and Human Immunodeficiency Virus (HIV) Infection in Selected Population Groups?
Its CFDA number is 93.943: Assistance Listing numbers were called CFDA numbers before 2018.
How much funding has Assistance Listing 93.943 awarded?
143 grant awards under 93.943 have obligated $313,216,345 in federal funds to 112 recipients.
Who receives the most funding from 93.943?
The recipients obligated the most under Epidemiologic Research Studies of Acquired Immunodeficiency Syndrome (AIDS) and Human Immunodeficiency Virus (HIV) Infection in Selected Population Groups are Johns Hopkins University ($40,685,040), City Of New York ($10,432,599) and National Blood Transfusion SE Rvices ($8,150,000).
Are there open grant opportunities under 93.943?
No opportunity listed under 93.943 is open now. The latest, Minority HIV Research Initiative (MARI): Epidemiologic, Behavioral, and Implementation Science Research in Racial/Ethnic Minority Communities Disproportionately Affected by HIV and Build Research Capacity Among Historically Underrepresented Researchers, was posted on October 11, 2023.
On GovTribe
See this program's full record
- Every grant award and opportunity under it
- Funding by recipient, agency and assistance type
- Alerts for new opportunities
- Ask GovTribe AI about this program